252 related articles for article (PubMed ID: 23062543)
1. Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.
Narula N; Favalli V; Tarantino P; Grasso M; Pilotto A; Bellazzi R; Serio A; Gambarin FI; Charron P; Meder B; Pinto Y; Elliott PM; Mogensen J; Bolognesi M; Bollati M; Arbustini E
J Am Coll Cardiol; 2012 Nov; 60(19):1916-20. PubMed ID: 23062543
[TBL] [Abstract][Full Text] [Related]
2. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
[TBL] [Abstract][Full Text] [Related]
3. High yield of LMNA mutations in patients with dilated cardiomyopathy and/or conduction disease referred to cardiogenetics outpatient clinics.
van Tintelen JP; Hofstra RM; Katerberg H; Rossenbacker T; Wiesfeld AC; du Marchie Sarvaas GJ; Wilde AA; van Langen IM; Nannenberg EA; van der Kooi AJ; Kraak M; van Gelder IC; van Veldhuisen DJ; Vos Y; van den Berg MP;
Am Heart J; 2007 Dec; 154(6):1130-9. PubMed ID: 18035086
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients.
Sylvius N; Bilinska ZT; Veinot JP; Fidzianska A; Bolongo PM; Poon S; McKeown P; Davies RA; Chan KL; Tang AS; Dyack S; Grzybowski J; Ruzyllo W; McBride H; Tesson F
J Med Genet; 2005 Aug; 42(8):639-47. PubMed ID: 16061563
[TBL] [Abstract][Full Text] [Related]
5. Effects of mechanical stress and carvedilol in lamin A/C-deficient dilated cardiomyopathy.
Chandar S; Yeo LS; Leimena C; Tan JC; Xiao XH; Nikolova-Krstevski V; Yasuoka Y; Gardiner-Garden M; Wu J; Kesteven S; Karlsdotter L; Natarajan S; Carlton A; Rainer S; Feneley MP; Fatkin D
Circ Res; 2010 Feb; 106(3):573-82. PubMed ID: 20019332
[TBL] [Abstract][Full Text] [Related]
6. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
[TBL] [Abstract][Full Text] [Related]
7. Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathy.
Perrot A; Hussein S; Ruppert V; Schmidt HH; Wehnert MS; Duong NT; Posch MG; Panek A; Dietz R; Kindermann I; Böhm M; Michalewska-Wludarczyk A; Richter A; Maisch B; Pankuweit S; Ozcelik C
Basic Res Cardiol; 2009 Jan; 104(1):90-9. PubMed ID: 18795223
[TBL] [Abstract][Full Text] [Related]
8. Lamin A/C mutation is independently associated with an increased risk of arterial and venous thromboembolic complications.
van Rijsingen IA; Bakker A; Azim D; Hermans-van Ast JF; van der Kooi AJ; van Tintelen JP; van den Berg MP; Christiaans I; Lekanne Dit Deprez RH; Wilde AA; Zwinderman AH; Meijers JC; Grootemaat AE; Nieuwland R; Pinto YM; Pinto-Sietsma SJ
Int J Cardiol; 2013 Sep; 168(1):472-7. PubMed ID: 23073275
[TBL] [Abstract][Full Text] [Related]
9. Dilated cardiomyopathy caused by LMNA mutations. Clinical and morphological studies.
Bilińska ZT; Sylvius N; Grzybowski J; Fidziańska A; Michalak E; Walczak E; Walski M; Bieganowska K; Szymaniak E; Kuśmierczyk-Droszcz B; Lubiszewska B; Wagner T; Tesson F; Ruzyłło W
Kardiol Pol; 2006 Aug; 64(8):812-9; discussion 820-1. PubMed ID: 16981056
[TBL] [Abstract][Full Text] [Related]
10. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease.
Arbustini E; Pilotto A; Repetto A; Grasso M; Negri A; Diegoli M; Campana C; Scelsi L; Baldini E; Gavazzi A; Tavazzi L
J Am Coll Cardiol; 2002 Mar; 39(6):981-90. PubMed ID: 11897440
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome and risk stratification in dilated cardiolaminopathies.
Pasotti M; Klersy C; Pilotto A; Marziliano N; Rapezzi C; Serio A; Mannarino S; Gambarin F; Favalli V; Grasso M; Agozzino M; Campana C; Gavazzi A; Febo O; Marini M; Landolina M; Mortara A; Piccolo G; Viganò M; Tavazzi L; Arbustini E
J Am Coll Cardiol; 2008 Oct; 52(15):1250-60. PubMed ID: 18926329
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
[TBL] [Abstract][Full Text] [Related]
13. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.
Nikolova V; Leimena C; McMahon AC; Tan JC; Chandar S; Jogia D; Kesteven SH; Michalicek J; Otway R; Verheyen F; Rainer S; Stewart CL; Martin D; Feneley MP; Fatkin D
J Clin Invest; 2004 Feb; 113(3):357-69. PubMed ID: 14755333
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation, Ser143Pro, in the lamin A/C gene is common in finnish patients with familial dilated cardiomyopathy.
Kärkkäinen S; Heliö T; Miettinen R; Tuomainen P; Peltola P; Rummukainen J; Ylitalo K; Kaartinen M; Kuusisto J; Toivonen L; Nieminen MS; Laakso M; Peuhkurinen K
Eur Heart J; 2004 May; 25(10):885-93. PubMed ID: 15140538
[TBL] [Abstract][Full Text] [Related]
15. Plasma microRNAs as biomarkers for Lamin A/C-related dilated cardiomyopathy.
Toro R; Blasco-Turrión S; Morales-Ponce FJ; Gonzalez P; Martínez-Camblor P; López-Granados A; Brugada R; Campuzano O; Pérez-Serra A; Rosa Longobardo F; Mangas A; Llorente-Cortes V; de Gonzalo-Calvo D
J Mol Med (Berl); 2018 Aug; 96(8):845-856. PubMed ID: 30008018
[TBL] [Abstract][Full Text] [Related]
16. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy.
Taylor MR; Slavov D; Gajewski A; Vlcek S; Ku L; Fain PR; Carniel E; Di Lenarda A; Sinagra G; Boucek MM; Cavanaugh J; Graw SL; Ruegg P; Feiger J; Zhu X; Ferguson DA; Bristow MR; Gotzmann J; Foisner R; Mestroni L;
Hum Mutat; 2005 Dec; 26(6):566-74. PubMed ID: 16247757
[TBL] [Abstract][Full Text] [Related]
17. R25G mutation in exon 1 of LMNA gene is associated with dilated cardiomyopathy and limb-girdle muscular dystrophy 1B.
Yuan WL; Huang CY; Wang JF; Xie SL; Nie RQ; Liu YM; Liu PM; Zhou SX; Chen SQ; Huang WJ
Chin Med J (Engl); 2009 Dec; 122(23):2840-5. PubMed ID: 20092787
[TBL] [Abstract][Full Text] [Related]
18. Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.
Gupta P; Bilinska ZT; Sylvius N; Boudreau E; Veinot JP; Labib S; Bolongo PM; Hamza A; Jackson T; Ploski R; Walski M; Grzybowski J; Walczak E; Religa G; Fidzianska A; Tesson F
Basic Res Cardiol; 2010 May; 105(3):365-77. PubMed ID: 20127487
[TBL] [Abstract][Full Text] [Related]
19. A novel deletion mutation accompanied by a point mutation in Lamin A/C gene: Screened from a dilated cardiomyopathy family.
Jia H; Sun Y; Yao W; Chen Z; Yang S; Wang C; Lu S
Perfusion; 2023 May; 38(4):826-836. PubMed ID: 35514053
[TBL] [Abstract][Full Text] [Related]
20. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]